Chemistry:1Bz-LSD

From HandWiki

1Bz-LSD, also known as 1-benzoyl-LSD or as SYN-L-018, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[1][2] It is thought to be a prodrug of LSD.[1][2] The drug was patented by Lizard Labs in 2024.[2] Subsequently, it was encountered online as a novel designer drug in July 2024.[1] 1Bz-LSD has been sold in the form of blotter tabs and microdots containing 10 μg and 200 μg doses per unit.[1] 1Bz-LSD is not an explicitly controlled substance in the United States[3] or in Canada.[4]

See also

  • Substituted lysergamide
  • 1SB-LSD

References